WHITEPAPER

Unlock the Future of Antibody Purification

Discover how novel antibody formats are reshaping biologics - and the purification strategies that make them viable.

The biologics landscape is evolving rapidly, with bispecific antibodies, Fab fragments, and nanobodies pushing the boundaries of therapeutic innovation. But with these advances come complex purification challenges that traditional methods can’t solve.

In this whitepaper, Beyond Traditional Monoclonal Antibodies, Ecolab’s Purolite™ team explores the latest purification technologies tailored for next-generation antibody formats. Learn how novel affinity resins like Praesto™ 70 CH1 and Jetted A50 HipH are enabling scalable, high-yield production while minimizing aggregation and impurity risks.

Whether you're a process development scientist, biopharma engineer, or regulatory strategist, this resource delivers actionable insights to optimize downstream workflows and accelerate time to market.